Targeting tumor necrosis factor in the brain relieves neuropathic pain

• 作者: Robert N Spengler Tracey A Ignatowski
• 来源期刊: 世界麻醉学杂志
• 学科: 医学
• 关键词: NEUROPATHIC PAIN Tumor NECROSIS factor BRAIN NOREPINEPHRINE ANALGESIA
• 年，卷（期）: 2018,（2）
• 页码范围: 10-19
• 页数: 10页
• 分类号: R

摘要

Neuropathic pain is a chronic syndrome caused by direct damage to or disease of the somatosensory nervous system.The lack of safe,adequate and sustained pain relief offered by present analgesic treatments is most alarming.While many treatment options are available to manage chronic pain,such as antidepressants,nonsteroidal anti-inflammatory agents,opioids,and anticonvulsants,chronic neuropathic pain remains largely unmanaged.Compounding the dilemma of ineffective chronic pain treatments is the need to provide relief from suffering and yet not contribute to the scourge of drug abuse.A recent epidemic of addiction and accidental drug prescription overdoses parallel the increased use of opioid treatment,even though opioids are rarely an effective treatment of relieving chronic pain.To make matters worse,opioids may contribute to exacerbating pain,and side-effects such as cognitive impairment,nausea,constipation,development of tolerance,as well as their potential for addiction and overdose deaths exist.Clearly,there is an urgent need for alternative,nonopiate treatment of chronic pain.Innovative discoveries of pertinent brain mechanisms and functions are key to developing effective,safe treatments.Pioneering work has revealed the essential effects of the pleiotropic mediator tumor necrosis factor(TNF)on brain functioning.These studies establish that TNF inhibits norepinephrine release from hippocampal neurons,and show that excess TNF production within the hippocampus occurs during neuropathic pain,which mobilizes additional mechanisms that further inhibit norepinephrine release.Significantly,it has been verified that elevated levels of TNF in the brain are actually required for neuropathic pain development.Since TNF decreases norepinephrine release in the brain,enhanced TNF levels would prevent engagement of the norepinephrine descending inhibitory neuronal pain pathways.Increased levels of TNF in the brain are therefore critical to the development of neuropathic pain.Therefore,strategies that decrease this enhanced